Pathophysiology, Diagnosis and Management of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum CardiomyopathyJohann Bauersachs, Karen Sliwa, Tobias König et al.|European Journal of Heart Failure|2019Cited by 435
Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM)Karen Sliwa, Johann Bauersachs, Alexandre Mebazaa et al.|European Journal of Heart Failure|2017Cited by 232
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registryKaren Sliwa, Johann Bauersachs, Mark C. Petrie et al.|European Heart Journal|2020Cited by 187
Long-Term Prognosis, Subsequent Pregnancy, Contraception and Overall Management of Peripartum Cardiomyopathy: Practical Guidance Paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum CardiomyopathyKaren Sliwa, Johann Bauersachs, Mark C. Petrie et al.|European Journal of Heart Failure|2018Cited by 146
Cardiovascular Toxicities of Immune Therapies for Cancer – A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-OncologyCarlo G. Tocchetti, Alexander R. Lyon, Teresa López‐Fernández et al.|European Journal of Heart Failure|2024Cited by 64